Rusan Pharma recently achieved a momentous milestone with the launch of its state-of-the-art API facility in Pithampur, Special Economic Zone (SEZ), Madhya Pradesh (MP).
With an approach to sustainable development and technological advancements, the total investment over two phases will be up to Rs 300 crore, highlighting Rusan Pharma’s commitment to the pharmaceutical sector and its potential impact on the industry’s growth and development.
The facility is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tonnes of APIs annually, the facility significantly contributes to Rusan Pharma’s growth and expansion plans, diversifying its portfolio and expanding its reach in India and other markets.
Strategically situated within the Pithampur SEZ, the new facility will capitalise on the support and subsidies provided by the Madhya Pradesh state government. This central location will streamline business operations and export processes through the dry port, making it an optimal choice for Rusan Pharma’s expansion plans. The facility’s location in a dedicated pharmaceutical zone ensures a cleaner environment, reducing the risk of pollution from other industries in the area.
During the construction phase of the Pithampur facility, over 3000 contract workers were employed, and once it is fully operational, the facility will directly generate more than 300 employment opportunities, and over the years, more than 500+ indirect employment opportunities will be created.
